blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP0624161

EP0624161 - 2'-DESOXY-ISOGUANOSINES, ISOSTER ANALOGUES AND ISOGUANOSINE DERIVATES AND THEIR USE [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  30.12.1999
Database last updated on 05.10.2024
Most recent event   Tooltip28.12.2007Lapse of the patent in a contracting state
New state(s): IT
published on 30.01.2008  [2008/05]
Applicant(s)For all designated states
Roche Diagnostics GmbH
Sandhofer Strasse 116
68305 Mannheim / DE
[N/P]
Former [1999/11]For all designated states
Roche Diagnostics GmbH
68298 Mannheim / DE
Former [1999/08]For all designated states
BOEHRINGER MANNHEIM GMBH
68298 Mannheim / DE
Former [1994/46]For all designated states
BOEHRINGER MANNHEIM GMBH
D-68298 Mannheim / DE
Inventor(s)01 / SEELA, Frank
Gutenbergstrasse 44
D-4500 Osnabrück / DE
02 / KASIMIERCZUK, Zigmunt
ul. Wasilkowskiego 12 m. 17
02-776 Warszawa / PL
03 / MÜHLEGGER, Klaus
Römerstrasse 7
D-8121 Polling / DE
04 / VON DER ELTZ, Herbert
In der Au 21
D-8120 Weilheim / DE
[1994/46]
Representative(s)Fouquet, Herbert, et al
Roche Diagnostics GmbH, Patentabteilung, Sandhofer Strasse 116
68305 Mannheim / DE
[N/P]
Former [1994/46]Fouquet, Herbert, Dr., et al
c/o Boehringer Mannheim GmbH, Patentabteilung, Sandhoferstrasse 116
D-68298 Mannheim / DE
Application number, filing date92924697.309.12.1992
[1994/46]
WO1992EP02843
Priority number, dateDE1991414046309.12.1991         Original published format: DE 4140463
[1994/46]
Filing languageDE
Procedural languageDE
PublicationType: A1 Application with search report
No.:WO9312130
Date:24.06.1993
Language:DE
[1993/15]
Type: A1 Application with search report 
No.:EP0624161
Date:17.11.1994
Language:DE
The application published by WIPO in one of the EPO official languages on 24.06.1993 takes the place of the publication of the European patent application.
[1994/46]
Type: B1 Patent specification 
No.:EP0624161
Date:24.02.1999
Language:DE
[1999/08]
Search report(s)International search report - published on:EP24.06.1993
ClassificationIPC:C07H21/00, C07H19/04, C12Q1/68
[1994/46]
CPC:
C07H21/00 (EP,US); A61P31/12 (EP); C07H19/04 (EP,US)
Designated contracting statesAT,   BE,   CH,   DE,   DK,   ES,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   NL,   PT,   SE [1994/46]
TitleGerman:2'-DESOXY-ISOGUANOSINE, ISOSTERE ANALOGE UND ISOGUANOSINDERIVATE SOWIE DEREN ANWENDUNG[1994/46]
English:2'-DESOXY-ISOGUANOSINES, ISOSTER ANALOGUES AND ISOGUANOSINE DERIVATES AND THEIR USE[1994/46]
French:2'-DESOXY-ISOGUANOSINES, ANALOGUES ISOSTERES ET DERIVES D'ISOGUANOSINE, AINSI QUE LEUR UTILISATION[1994/46]
Entry into regional phase26.05.1994National basic fee paid 
26.05.1994Designation fee(s) paid 
26.05.1994Examination fee paid 
Examination procedure29.03.1993Request for preliminary examination filed
International Preliminary Examining Authority: EP
26.05.1994Examination requested  [1994/46]
06.02.1996Despatch of a communication from the examining division (Time limit: M04)
23.05.1996Reply to a communication from the examining division
10.06.1996Despatch of a communication from the examining division (Time limit: M04)
16.10.1996Reply to a communication from the examining division
21.02.1997Despatch of a communication from the examining division (Time limit: M04)
10.06.1997Reply to a communication from the examining division
24.02.1998Despatch of communication of intention to grant (Approval: No)
09.05.1998Despatch of communication of intention to grant (Approval: later approval)
24.07.1998Communication of intention to grant the patent
15.10.1998Fee for grant paid
15.10.1998Fee for publishing/printing paid
Opposition(s)25.11.1999No opposition filed within time limit [2000/07]
Fees paidRenewal fee
10.12.1994Renewal fee patent year 03
20.12.1995Renewal fee patent year 04
16.12.1996Renewal fee patent year 05
10.12.1997Renewal fee patent year 06
09.12.1998Renewal fee patent year 07
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipES24.02.1999
GR24.02.1999
IT24.02.1999
NL24.02.1999
SE24.02.1999
DK24.05.1999
PT24.05.1999
IE19.10.1999
[2008/05]
Former [2003/45]ES24.02.1999
GR24.02.1999
NL24.02.1999
SE24.02.1999
DK24.05.1999
PT24.05.1999
IE19.10.1999
Former [2003/07]ES24.02.1999
GR24.02.1999
NL24.02.1999
SE24.02.1999
PT24.05.1999
IE19.10.1999
Former [2002/25]ES24.02.1999
GR24.02.1999
SE24.02.1999
PT24.05.1999
IE19.10.1999
Former [2002/23]GR24.02.1999
SE24.02.1999
PT24.05.1999
IE19.10.1999
Former [2002/10]GR24.02.1999
PT24.05.1999
IE19.10.1999
Former [2001/23]GR24.02.1999
IE24.02.1999
PT24.05.1999
Former [2000/27]IE24.02.1999
PT24.05.1999
Former [2000/23]PT24.05.1999
Cited inInternational search[X]EP0219838  (TAKEDA CHEMICAL INDUSTRIES LTD [JP]);
 [Y]EP0269445  (CETUS CORP [US], et al);
 [X]EP0286028  (BOEHRINGER MANNHEIM GMBH [DE]);
 [X]WO9003370  (MICROPROBE CORP [US]);
 [X]WO9006312  (INST MOLEKULARBIOLOGIE UND ANA [DE])
 [X]  - NUCLEIC ACIDS RESEARCH. Bd. 11, Nr. 3, 11. Februar 1983, ARLINGTON, VIRGINIA US Seiten 871 - 882 H.B.COTTAM ET AL. 'A Convenient Synthesis of 6-Amino-1-B-D-ribofuranosylpyrazolo(3,4 -d)pyrimidin-4-one and Related 4,6-Disubstituted Pyrazolopyrimidine Nucleosides.'
 [XP]  - HELVETICA CHIMICA ACTA. Bd. 74, Nr. 8, 11. Dezember 1991, BASEL CH Seiten 1742 - 1748 Z.KAZIMIERCZUK ET AL. '168. 2'-Deoxyguanosine and Base-Modified Analogues: Chemical and Photochemical Synthesis.'
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.